Special Investigation For Renal Cell Carcinoma (RCC) Of Sutent (Regulatory Post Marketing Commitment Plan)
All the patients whom an investigator prescribes the first sunitinib malate(Sutent) should
Observational Model: Case-Only, Time Perspective: Prospective
Adverse drug reaction not expected from the LPD (unknown adverse drug reaction).
Pfizer CT.gov Call Center
Japan: Ministry of Health, Labor and Welfare